輸入代號或公司名稱後按 Enter
3176

基亞

-0.20 (-0.53%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
37.85688成交張數本益比3.59股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20251,583年增 +15.3%
毛利率202557.2%最新一期
營業利益率2025-9.9%最新一期
每股盈餘2025-0.78
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計73.3%65.8%70.7%53.6%57.2%34.9%91.7%46.7%45.1%42.8%
營業毛利(毛損)26.7%34.2%29.3%46.4%42.8%65.1%8.3%53.3%54.9%57.2%
未實現銷貨(損)益0.2%0.0%3.0%
營業毛利(毛損)淨額26.7%34.2%29.3%46.4%42.6%65.1%8.3%53.3%54.9%54.2%
營業費用合計214.3%191.2%216.5%184.4%190.8%45.0%166.1%159.8%70.7%64.1%
營業利益(損失)-187.6%-157.0%-187.2%-138.0%-148.2%20.1%-157.9%-106.5%-15.8%-9.9%
稅前淨利(淨損)-233.4%-170.2%-192.6%-148.1%-143.0%29.0%-177.3%-110.5%-8.2%-13.8%
所得稅費用(利益)合計-10.2%-0.1%3.9%1.6%-5.3%1.7%5.6%16.5%8.0%4.9%
繼續營業單位本期淨利(淨損)-223.2%-170.1%-196.5%-149.6%-137.7%27.3%-182.9%-127.0%-16.2%-18.7%
本期淨利(淨損)-223.2%-170.1%-208.0%-124.6%-137.7%27.3%-182.9%-127.0%-16.2%-18.7%
本期綜合損益總額-221.9%-171.6%-206.0%-113.1%-147.0%26.5%-175.3%-125.6%-9.9%-28.4%
母公司業主(淨利∕損)-142.1%-102.0%-108.7%-46.3%-54.9%-1.3%-64.0%-48.5%-14.9%-6.9%
基本每股盈餘-1.0%-0.7%-0.8%-0.3%-0.4%-0.0%-0.5%-0.3%-0.1%-0.0%
已實現銷貨(損)益0.0%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。